Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?

被引:16
|
作者
Anwar, Sirajudheen [1 ,2 ,3 ]
Malik, Jonaid Ahmad [4 ,5 ]
Ahmed, Sakeel [6 ]
Kameshwar, Verma Abhishek [7 ]
Alanazi, Jowaher [1 ,2 ,3 ]
Alamri, Abdulwahab [1 ,2 ,3 ]
Ahemad, Nafees [8 ]
机构
[1] Univ Hail, Coll Pharm, Dept Pharmacol & Toxicol, Hail 81422, Saudi Arabia
[2] Univ Hail, Mol Diagnost Unit, Hail 81422, Saudi Arabia
[3] Univ Hail, Personalized Treatment, Hail 81422, Saudi Arabia
[4] Natl Inst Pharmaceut Educ & Res, Dept Pharmacol & Toxicol, Gauhati 781101, Assam, India
[5] Indian Inst Technol Ropar, Dept Biomed Engn, Rupnagar 140001, Punjab, India
[6] Natl Inst Pharmaceut Educ & Res, Dept Pharmacol & Toxicol, Ahmadabad 382355, Gujarat, India
[7] Amrita Vishwa Vidyapeetham, Dept Pharmacol, Amrita Sch Pharm, Kochi 641112, Kerala, India
[8] Monash Univ Malaysia, Sch Pharm, Jalan Lagoon Selatan, Petaling Jaya 47500, Selangor De, Malaysia
来源
MOLECULES | 2022年 / 27卷 / 22期
关键词
epithelial-mesenchymal transition; cancer EMT; natural chemical entities; cancer; anticancer therapy; chemotherapy; EPITHELIAL-MESENCHYMAL TRANSITION; SPONGE CHONDROSIA-CORTICATA; GROWTH-FACTOR-BETA; NF-KAPPA-B; BREAST-CANCER; DOXORUBICIN RESISTANCE; MULTIDRUG-RESISTANCE; LUTEOLIN SUPPRESSES; DRUG-RESISTANCE; DOWN-REGULATION;
D O I
10.3390/molecules27227668
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer is the leading cause of death and has remained a big challenge for the scientific community. Because of the growing concerns, new therapeutic regimens are highly demanded to decrease the global burden. Despite advancements in chemotherapy, drug resistance is still a major hurdle to successful treatment. The primary challenge should be identifying and developing appropriate therapeutics for cancer patients to improve their survival. Multiple pathways are dysregulated in cancers, including disturbance in cellular metabolism, cell cycle, apoptosis, or epigenetic alterations. Over the last two decades, natural products have been a major research interest due to their therapeutic potential in various ailments. Natural compounds seem to be an alternative option for cancer management. Natural substances derived from plants and marine sources have been shown to have anti-cancer activity in preclinical settings. They might be proved as a sword to kill cancerous cells. The present review attempted to consolidate the available information on natural compounds derived from plants and marine sources and their anti-cancer potential underlying EMT mechanisms.
引用
收藏
页数:20
相关论文
共 50 条
  • [41] Natural products for chronic cough: Text mining the East Asian historical literature for future therapeutics
    Shergis, Johannah Linda
    Wu, Lei
    May, Brian H.
    Zhang, Anthony Lin
    Guo, Xinfeng
    Lu, Chuanjian
    Xue, Charlie Changli
    CHRONIC RESPIRATORY DISEASE, 2015, 12 (03) : 204 - 211
  • [42] Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease
    Xu, Jingqi
    Shen, Jiayan
    Yuan, Ruolan
    Jia, Bona
    Zhang, Yiwen
    Wang, Sijian
    Zhang, Yi
    Liu, Mengyang
    Wang, Tao
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [43] A peptide derived from interleukin-10 exhibits potential anticancer activity and can facilitate cell targeting of gold nanoparticles loaded with anticancer therapeutics
    Chang, Chun-Chun
    Yang, Chin-Hao
    Chuang, Chin-Hsien
    Jiang, Shinn-Jong
    Hwang, Yin-Min
    Liou, Je-Wen
    Hsu, Hao-Jen
    COMMUNICATIONS CHEMISTRY, 2023, 6 (01)
  • [44] A peptide derived from interleukin-10 exhibits potential anticancer activity and can facilitate cell targeting of gold nanoparticles loaded with anticancer therapeutics
    Chun-Chun Chang
    Chin-Hao Yang
    Chin-Hsien Chuang
    Shinn-Jong Jiang
    Yin-Min Hwang
    Je-Wen Liou
    Hao-Jen Hsu
    Communications Chemistry, 6
  • [45] Natural Cyclic Peptides as Clinical and Future Therapeutics
    Bera, Smritilekha
    Mondal, Dhananjoy
    CURRENT ORGANIC CHEMISTRY, 2019, 23 (01) : 38 - 75
  • [46] Genetically engineered biopolymer conjugate for thermal targeting of anticancer therapeutics.
    Chilkoti, A
    Meyer, DE
    Kong, GH
    Dewhirst, MW
    Foulon, C
    Zalutsky, MR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U453 - U453
  • [47] The Potential of Combining Tubulin-Targeting Anticancer Therapeutics and Immune Therapy
    Fong, Alexis
    Durkin, Amanda
    Lee, Hoyun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (03)
  • [48] Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics
    Chen, Hao
    Smaill, Jeff B.
    Liu, Tongzheng
    Ding, Ke
    Lu, Xiaoyun
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (23) : 14404 - 14424
  • [49] HDL-Targeting Therapeutics: Past, Present and Future
    Zakiev, Emile
    Feng, Ma
    Sukhorukov, Vasily
    Kontush, Anatol
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (08) : 1207 - 1215
  • [50] Engineering the future of medicine: Natural products, synthetic biology and artificial intelligence for next-generation therapeutics
    Buelbuel, Emre F.
    Bode, Helge B.
    Schmitt, Steven
    Bozhueyuek, Kenan A. J.
    CLINICAL AND TRANSLATIONAL MEDICINE, 2025, 15 (02):